Market Trends of Apoptosis Assay Industry
This section covers the major market trends shaping the Apoptosis Assay Market according to our research experts:
Assay Kits Segment is Expected to Hold the Largest Market Share in the Apoptosis Assay Market
- Assay kits identify and quantify cell events related to programmed cell death, involving caspase initiation, phosphatidylserine (PS) cell surface exposure and DNA fragmentation.
- The number of repetitive consumption of assay in numerous other apoptosis processes can propel the demand of the assay kits during the forecast period.
- The rising incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others is also boosting the market growth. As per the statistics from GLOBOCAN 2018, worldwide 18,078,957 individuals have cancer. Asia remains the leading contributor in the rising incidence of cancer with a reported share of 48.4% followed by Europe, North and Latin America, Africa, and Oceania with a share of 23.4%, 13.2% and 7.8%, 5.8%, and 1.4% respectively.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall apoptosis assay market, throughout the forecast period. This is owing to the factors such as the rising incidence of chronic diseases such as cancer and the availability of advanced healthcare infrastructure among the major factors. In North America region, the United States holds the largest market share owing to the factors such as increasing number of population suffering from autoimmune diseases and chronic disease, along with the rising geriatric population and developments related to apoptosis-modulating drugs in the country, is anticipated to stimulate the demand in this region.
